|
|
 | | | |
- close
- close
- close
- close
| |||||||||
These excerpts taken from the MGRM 10-K filed Feb 13, 2009. Authorized Common Stock On October 27, 2008, the Company’s Board of Directors approved a 6-to-1 reverse stock split, as previously authorized and approved by the Company’s stockholders at the September 19, 2007 annual meeting, which became effective on November 4, 2008. In addition, the Company reduced the number of authorized shares of common stock from 200,000,000 shares to 84,000,000 shares of which 22,871,670 shares were outstanding at December 31, 2008. Authorized On October 27, 2008, the Company’s Board of Directors approved a 6-to-1 reverse stock split, as previously These excerpts taken from the MGRM 10-K filed Mar 12, 2008. Authorized Common Stock The Company has 200,000,000 authorized shares of common stock as of December 31, 2007. Authorized Common Stock The This excerpt taken from the MGRM 10-K filed Mar 9, 2007. Authorized Common Stock In 2004, Monogram Biosciences’ stockholders approved an increase to the number of authorized shares of the Company’s common stock from 100,000,000 shares to 200,000,000 shares. This excerpt taken from the MGRM 10-K filed Mar 16, 2006. Authorized Common Stock
In 2004, Monogram Biosciences’ stockholders approved an increase to the number of authorized shares of the Company’s common stock from 100,000,000 shares to 200,000,000 shares.
This excerpt taken from the MGRM 10-Q filed Nov 8, 2005. Authorized Common Stock
In 2004, Monogram Biosciences’ stockholders approved an increase to the number of authorized shares of the Company’s common stock from 100,000,000 shares to 200,000,000 shares.
This excerpt taken from the MGRM 10-Q filed Aug 8, 2005. Authorized Common Stock
In 2004, ViroLogic’s stockholders approved an increase to the number of authorized shares of the Company’s common stock from 100,000,000 shares to 200,000,000 shares.
This excerpt taken from the MGRM 10-Q filed May 10, 2005. Authorized Common Stock
In 2004, ViroLogic’s stockholders approved an increase to the number of authorized shares of the Company’s common stock from 100,000,000 shares to 200,000,000 shares.
This excerpt taken from the MGRM 10-K filed Mar 16, 2005. Authorized Common Stock
In 2004, ViroLogic’s stockholders approved an increase to the number of authorized shares of the Company’s common stock from 100,000,000 shares to 200,000,000 shares.
| EXCERPTS ON THIS PAGE:
RELATED TOPICS for MGRM: |
| |||||||
